Medical Devices Startups

RenovoDerm is a life sciences company developing wound care and tissue technology platforms within the medtech and biotech sectors. It operates as a commercial subsidiary of Paragen Technologies.

1 investor

Reopia develops advanced optical solutions that prevent the onset and progression of myopia in children. The company addresses the growing global epidemic of nearsightedness through medical devices targeting pediatric eye health.

1 investor

REPROSENT captures patient treatment experience data to support dose, safety, and development decisions in oncology and advanced cancer therapies. The platform operates as a lightweight, non-interventional overlay on existing clinical trials and care programs, converting patient symptoms into structured, computable signal for development and clinical teams.

1 investor

Everlife-Research Instruments supplies research tools, laboratory equipment, and analytical solutions to the scientific and clinical community in Asia. The company provides a full range of services from product distribution to technical support, regulatory guidance, and laboratory design.

1 investor

ResetSmile provides at-home tooth replacement solutions using a patented system that allows patients to replace missing teeth without visiting a dental office. The company serves the approximately 140 million Americans who have been underserved by traditional dental care options.

1 investor

Resilient Medical Corp designs an implantable device, Bravo, placed during breast cancer lumpectomy surgery to support tissue healing, avoid follow-up cosmetic reconstruction, and act as a radiocontrast marker for post-operative therapy. The company targets breast cancer surgical patients and clinicians in the medical device industry.

1 investor

Resolian is a Contract Research Organization (CRO) that provides bioanalytical, biomarker, and analytical sciences services to support drug development for pharma and biotech companies. The company specializes in GxP and non-regulated bioanalysis, drug metabolism and pharmacokinetic services, and GMP CMC analytical and materials science across all therapeutic modalities.

1 investor

Resolution develops a macrophage cell therapy to treat end-stage liver disease, aiming to reduce the need for liver transplantation and improve patient outcomes. The company focuses on regenerative medicine for inflammatory and fibrotic diseases.

1 investor

Resolve Nanotherapeutics is developing RNA drugs delivered via lipid nanoparticles that amplify the body's toxin-clearance pathway to treat severe acute bacterial infections and their chronic complications. Its host-focused therapy targets the immune system rather than the bacteria, aiming to work against antibiotic-resistant infections in critical care settings.

1 investor

Résonance Imagerie is a network of medical imaging centers staffed by specialized radiologists, offering diagnostic imaging services such as MRI to patients. Its centers are located across Île-de-France, Centre-Val de Loire, Hauts-de-France, and Normandie in France.

1 investor

Respira provided clinical respiratory services, sleep, home medical equipment, and home health care to patients across the Mid-Atlantic Region. The company ceased business operations as of March 9, 2018.

1 investor

Response Bio develops the RAMP platform, which delivers acute care diagnostic testing with lab-quality results within minutes to support rapid clinical decision-making in healthcare settings. The company serves medical teams and partners seeking to reduce diagnostic turnaround time and total cost of care.

1 investor

Restore Medical is a medical device company in the cardiology field, developing technology associated with interventional cardiology and cardiac research.

1 investor

Resurgens Orthopaedics is a medical practice providing orthopedic care including sports medicine, joint replacement, and surgical services to patients in the Fayetteville, Georgia area and surrounding south Metro Atlanta region. The practice operates multiple facilities offering physician services, on-site MRI imaging, rehabilitation therapy, and urgent care.

1 investor

Resuscitec develops and produces extracorporeal cardiopulmonary resuscitation technology for emergency and intensive care medicine. The company serves hospitals and emergency services with CARL Technology systems for both in-hospital and out-of-hospital resuscitation applications.

1 investor

ResVent develops respiratory and critical care medical devices, including invasive and non-invasive ventilators and diagnostic equipment for hospital critical care and chronic respiratory disease management.

1 investor

Retia Medical develops advanced hemodynamic monitoring devices, including the Argos Cardiac Output Monitor, which uses proprietary algorithms to provide real-time clinical decision support for high-risk patients. The company's products support clinicians in critical care and perioperative settings.

1 investor

Reticular provides genetic screening and embryo analysis for prospective parents, offering risk assessments for pregnancy loss, inherited diseases, and health traits to inform reproductive decisions.

1 investor

RetiDiag provides teleophthalmology services and visual health field operations to detect, evaluate, and monitor eye conditions, connecting clinical teams and professionals to improve access to specialized eye care. It serves health institutions such as primary care centers (CESFAM), hospitals, municipalities, and health organizations, with a focus on communities with limited access to specialized care in Chile.

1 investor

RetinaCheck was a Sino-Dutch research project and TU/e startup that developed computer-aided diagnosis software using geometric methods and deep learning to automatically analyze retinal fundus images for early detection of diabetic retinopathy and other eye diseases. Aimed at large-scale diabetes screening programs in China, the startup was acquired by the He Vision Group in 2020.

1 investor

RetMap develops next-generation electroretinography sensors and diagnostic medical devices for screening, diagnosis, and treatment of neurodegenerative eye conditions. The company serves ophthalmologists and clinicians seeking to detect and manage retinal diseases and prevent vision loss.

1 investor

RevMed is an advanced regenerative medicine company focused on researching and developing therapeutic solutions in the regenerative medicine field. The company aims to extend human lifespan and improve health outcomes through life-centered innovation.

1 investor

Revadix develops first-in-class small molecule therapies targeting the EPAC1 signalling pathway to treat atrial fibrillation, addressing the underlying disease mechanism rather than symptoms. Its lead asset AM-001 is entering IND-enabling studies while a second EPAC1-targeting program is in lead optimization, aimed at cardiac arrhythmia patients.

1 investor

Revagenix is a precision-therapeutics company that develops drugs for serious chronic diseases, starting from the underlying biology and unmet clinical needs. Its lead program, Rev-56, is an inhaled therapy with a novel mechanism of action designed for non-CF bronchiectasis (NCFB).

1 investor